Skip to main content

Dose Optimization Informed by PBPK Modeling: State-of-the Art and Future

Model-informed drug development (MIDD) is a powerful quantitative approach that plays an integral role in drug development and regulatory review. While applied throughout the life cycle of …

Author(s): Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen

Year: April 30, 2024